Small molecule inhibitors targeting the cancers

por Liu, Gui‐Hong, Chen, Tao, Zhang, Xin, Ma, Xue‐Lei, Shi, Hua‐Shan
Publicado 2022

Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma

por Tang, You-Yin, Zhao, Yu-Nuo, Zhang, Tao, Chen, Zhe-Yu, Ma, Xue-Lei
Publicado 2021

Prediction of Overall Survival and Progression-Free Survival by the (18)F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma

por Zhou, Yi, Ma, Xue-Lei, Pu, Lu-Tong, Zhou, Ruo-Fan, Ou, Xue-Jin, Tian, Rong
Publicado 2019

Progress in Neoantigen Targeted Cancer Immunotherapies

por Han, Xue-Jiao, Ma, Xue-lei, Yang, Li, Wei, Yu-quan, Peng, Yong, Wei, Xia-wei
Publicado 2020

Inflammation‐nutritional markers of peripheral blood could predict survival in advanced non‐small‐cell lung cancer patients treated with PD‐1 inhibitors

por Pu, Dan, Xu, Qian, Zhou, Lai‐Yan, Zhou, Yu‐Wen, Liu, Ji‐Yan, Ma, Xue‐Lei
Publicado 2021

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

por Zhou, Yu-Wen, Xie, Yao, Tang, Lian-Sha, Pu, Dan, Zhu, Ya-Juan, Liu, Ji-Yan, Ma, Xue-Lei
Publicado 2021